date:Sep 28, 2018
r allergens, so that we can prevent them from even initiating a response.
In other words, Regeneron is working on determining what it is about cats, or pollen, or peanuts, that triggers allergic reactions, and is developing medicines to block those molecules from irritating the immune system.
We know what the major driver is from the cat allergen that's inducing a lot of the symptoms, and we demonstrated this pre-clinically in these labs, Orengo said. Then we actually took it into a phase 1 cl